Barclays raised the firm’s price target on Fresenius Medical (FMS) to EUR 41 from EUR 39 and keeps an Equal Weight rating on the shares.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on FMS:
- Fresenius Medical’s Novalung ECMO System selected by Premier
- Fresenius Medical price target raised to EUR 39 from EUR 38.50 at Barclays
- Fresenius Medical price target raised to EUR 37.30 from EUR 35.40 at JPMorgan
- Fresenius Medical ADRs initiated with a Buy at Berenberg
- Fresenius Medical Care Reports Strong Q3 2024 Results